Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

According to a comparative analysis conducted based on propensity score matching, anti–PD-1 therapy with either pembrolizumab (Keytruda) or nivolumab (Opdivo) significantly improved overall survival (

PD-1 Inhibitors Demonstrate Promise as Salvage Therapy in R/R Extranodal NK/T-cell Lymphoma

According to a comparative analysis conducted based on propensity score matching, anti–PD-1 therapy with either pembrolizumab (Keytruda) or nivolumab (Opdivo) significantly improved overall survival (
New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.The INTER

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.The INTER
UTHealth Houston study to examine how eviction protection during the pandemic affects mental health

UTHealth Houston study to examine how eviction protection during the pandemic affects mental health

During the COVID-19 pandemic, eviction moratoria prevented or delayed many people from experiencing homelessness. But now that the pandemic is over and the short-term eviction protection has ended, th

UTHealth Houston study to examine how eviction protection during the pandemic affects mental health

During the COVID-19 pandemic, eviction moratoria prevented or delayed many people from experiencing homelessness. But now that the pandemic is over and the short-term eviction protection has ended, th
mRNA-4157 Plus Pembrolizumab Under Further Investigation in Phase 3 Trial in High-Risk Melanoma

mRNA-4157 Plus Pembrolizumab Under Further Investigation in Phase 3 Trial in High-Risk Melanoma

The combination of mRNA-4157 (V940) and pembrolizumab (Keytruda) will be further evaluated as an adjuvant treatment option for patients with resected, high-risk, stage IIB to IV melanoma in the phase

mRNA-4157 Plus Pembrolizumab Under Further Investigation in Phase 3 Trial in High-Risk Melanoma

The combination of mRNA-4157 (V940) and pembrolizumab (Keytruda) will be further evaluated as an adjuvant treatment option for patients with resected, high-risk, stage IIB to IV melanoma in the phase
Butterfly-inspired imaging sensor can detect cancer cells with high accuracy

Butterfly-inspired imaging sensor can detect cancer cells with high accuracy

There are many creatures on our planet with more advanced senses than humans. Turtles can sense Earth's magnetic field. Mantis shrimp can detect polarized light. Elephants can hear much lower freq

Butterfly-inspired imaging sensor can detect cancer cells with high accuracy

There are many creatures on our planet with more advanced senses than humans. Turtles can sense Earth's magnetic field. Mantis shrimp can detect polarized light. Elephants can hear much lower freq
Kirtane Highlights Uniqueness of Solid Tumor CAR T-Cell Agent A2B530

Kirtane Highlights Uniqueness of Solid Tumor CAR T-Cell Agent A2B530

For patients with solid tumors, investigators have faced hurdles replicating successes with chimeric antigen receptor (CAR) T-cell therapies. The novel CAR T-cell agent A2B530, looks to forge a pathwa

Kirtane Highlights Uniqueness of Solid Tumor CAR T-Cell Agent A2B530

For patients with solid tumors, investigators have faced hurdles replicating successes with chimeric antigen receptor (CAR) T-cell therapies. The novel CAR T-cell agent A2B530, looks to forge a pathwa
From Mount Everest to your liver: The alarming reach of 'forever chemicals' in our environment and health

From Mount Everest to your liver: The alarming reach of 'forever chemicals' in our environment and health

In a recent review published in the journalScience of The Total Environment,researchers collate and discuss available literature on per- and polyfluoroalkyl substances (PFAS). They highlig

From Mount Everest to your liver: The alarming reach of 'forever chemicals' in our environment and health

In a recent review published in the journalScience of The Total Environment,researchers collate and discuss available literature on per- and polyfluoroalkyl substances (PFAS). They highlig
INDIGO Trial Supports Vorasidenib as Effective Targeted Therapeutic in IDH1/2+ Low-Grade Glioma

INDIGO Trial Supports Vorasidenib as Effective Targeted Therapeutic in IDH1/2+ Low-Grade Glioma

Practice-changing safety and efficacy findings from the phase 3 INDIGO trial (NCT04164901) underscore the value of adding vorasidenib (AG-881) to the treatment armamentarium inIDH1/2-mutant glio

INDIGO Trial Supports Vorasidenib as Effective Targeted Therapeutic in IDH1/2+ Low-Grade Glioma

Practice-changing safety and efficacy findings from the phase 3 INDIGO trial (NCT04164901) underscore the value of adding vorasidenib (AG-881) to the treatment armamentarium inIDH1/2-mutant glio
Herrera Spotlights Key Research Across Hematologic Malignancies From the 2023 ASCO Annual Meeting

Herrera Spotlights Key Research Across Hematologic Malignancies From the 2023 ASCO Annual Meeting

Positive findings from thephase 3 SWOG S1826 trial(NCT03907488) have set the stage for ongoing efforts to align the treatment of adult and pediatric patients with newly diagnosed stage III

Herrera Spotlights Key Research Across Hematologic Malignancies From the 2023 ASCO Annual Meeting

Positive findings from thephase 3 SWOG S1826 trial(NCT03907488) have set the stage for ongoing efforts to align the treatment of adult and pediatric patients with newly diagnosed stage III
AI-assisted smartphone app performs well in skin cancer diagnosis

AI-assisted smartphone app performs well in skin cancer diagnosis

Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna investigated the extent to which

AI-assisted smartphone app performs well in skin cancer diagnosis

Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna investigated the extent to which
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...